Covid-19 man­u­fac­tur­ing roundup: Kenya will add man­u­fac­tur­ing plant, up vac­ci­na­tion sites; South Ko­rea left wait­ing on Rus­sia vac­cine ex­ports

A fill-and-fin­ish man­u­fac­tur­ing site is pop­ping up in Kenya to help as­sure Covid-19 vac­cine sup­ply, the min­istry of health an­nounced Wednes­day.

The site will help third-par­ty drug­mak­ers put vac­cines in­to vials. As a re­sult, Kenya’s vac­ci­na­tion sites will more than triple — to 3,000 from 800 — lead­ing to the dou­bling of vac­cines in arms by De­cem­ber, Bloomberg re­port­ed.

Africa has been fo­cused on self-sus­tain­abil­i­ty on the Covid-19 vac­ci­na­tion front. In ear­ly Sep­tem­ber, BioN­Tech an­nounced it is con­sid­er­ing putting vac­cine man­u­fac­tur­ing sites in Rwan­da and Sene­gal to help beef up the con­ti­nent’s sup­ply.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.